These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38797232)

  • 1. Harnessing genetic interactions for prediction of immune checkpoint inhibitors response signature in cancer cells.
    Liu M; Zhao Z; Wang C; Sang S; Cui Y; Lv C; Yang X; Zhang N; Xiong K; Chen B; Dong Q; Liu K; Gu Y
    Cancer Lett; 2024 Jul; 594():216991. PubMed ID: 38797232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma.
    Coleman S; Xie M; Tarhini AA; Tan AC
    Mol Carcinog; 2023 Jan; 62(1):77-89. PubMed ID: 35781709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma.
    Jiang J; Ding Y; Wu M; Chen Y; Lyu X; Lu J; Wang H; Teng L
    Cancer Med; 2020 Nov; 9(22):8498-8518. PubMed ID: 32969604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors.
    Davis-Marcisak EF; Fitzgerald AA; Kessler MD; Danilova L; Jaffee EM; Zaidi N; Weiner LM; Fertig EJ
    Genome Med; 2021 Aug; 13(1):129. PubMed ID: 34376232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of Dominant Peripheral T Cell Receptor Clone and Soluble Immune Checkpoint Proteins Associated With Clinical Outcomes Following Immune Checkpoint Inhibitor Treatment in Advanced Cancers.
    Li Y; Wang J; Wu L; Li X; Zhang X; Zhang G; Xu S; Sun S; Jiao S
    Front Immunol; 2021; 12():649343. PubMed ID: 34163469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of Resistance to Checkpoint Inhibitors.
    Tran L; Theodorescu D
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies.
    Pérez-Ruiz E; Melero I; Kopecka J; Sarmento-Ribeiro AB; García-Aranda M; De Las Rivas J
    Drug Resist Updat; 2020 Dec; 53():100718. PubMed ID: 32736034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
    Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
    Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in TP53 Are a Potential Biomarker of Bladder Cancer Patients Who Benefit From Immune Checkpoint Inhibition.
    Lyu Q; Lin A; Cao M; Xu A; Luo P; Zhang J
    Cancer Control; 2020; 27(1):1073274820976665. PubMed ID: 33356494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust Prediction of Immune Checkpoint Inhibition Therapy for Non-Small Cell Lung Cancer.
    Jiang J; Jin Z; Zhang Y; Peng L; Zhang Y; Zhu Z; Wang Y; Tong D; Yang Y; Wang J; Yang Y; Xiao K
    Front Immunol; 2021; 12():646874. PubMed ID: 33927719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of immune checkpoint inhibitors in the revolutionization of advanced melanoma care.
    Singh S; Numan A; Agrawal N; Tambuwala MM; Singh V; Kesharwani P
    Int Immunopharmacol; 2020 Jun; 83():106417. PubMed ID: 32200155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Signatures of NK Cell-Mediated Melanoma Killing Predict Response to Immunotherapies.
    Cappello S; Sung HM; Ickes C; Gibhardt CS; Vultur A; Bhat H; Hu Z; Brafford P; Denger A; Stejerean-Todoran I; Köhn RM; Lorenz V; Künzel N; Salinas G; Stanisz H; Legler T; Rehling P; Schön MP; Lang KS; Helms V; Herlyn M; Hoth M; Kummerow C; Bogeski I
    Cancer Res; 2021 Nov; 81(21):5540-5554. PubMed ID: 34518212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma.
    Nguyen MT; Luo YH; Li AL; Tsai JC; Wu KL; Chung PJ; Ma N
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in Melanoma.
    Zhang W; Kong Y; Li Y; Shi F; Lyu J; Sheng C; Wang S; Wang Q
    Front Immunol; 2021; 12():798474. PubMed ID: 35087523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic viability induces resistance to immune checkpoint inhibitors in cancer cells.
    Liu M; Dong Q; Chen B; Liu K; Zhao Z; Wang Y; Zhuang S; Han H; Shi X; Jin Z; Hui Y; Gu Y
    Br J Cancer; 2023 Oct; 129(8):1339-1349. PubMed ID: 37620409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma.
    Zhang W; Xia H; Yang R; Zhang Y; Zheng Q; Shang X; Liu N; Ma X; Wei C; Chen H; Mu X; Wang X; Liu Y
    Front Immunol; 2022; 13():1030969. PubMed ID: 36426352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
    Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
    Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Tumor Microenvironment in Melanoma Patients with In-Transit Metastases and Its Impacts on Immune Checkpoint Immunotherapy Responses.
    Tian J; Quek C
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-gene signature: a new tool for patient selection for checkpoint inhibitors?
    Sobhani N; Corona SP; Roviello G; Bagby S; D'Angelo A; Iezzi G; Generali D
    Future Oncol; 2020 Jul; 16(19):1327-1330. PubMed ID: 32396404
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive Value of
    Chen XJ; Ren AQ; Zheng L; Zheng ED
    Front Immunol; 2021; 12():664847. PubMed ID: 33953726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.